News and blogs
20 results found.
Evusheld – does it work against Omicron?
Evusheld Covid antibody treatment - what you need to know
Find out more about the Covid antibody treatment Evusheld (formely AZD7442), which consists of two long-acting antibodies called tixagevumab and cilgavimab.
Our response to Evusheld – a treatment to prevent Covid for the immunosuppressed
While we welcome the news of a new Covid treatment for immunosuppressed people – called Evusheld – we call for the Government to urgently set out its approach on how it will use preventative treatments for them.
Why are people with blood cancer invited for a 5th vaccine dose (second booster)?
People with blood cancer are now being offered a second covid vaccine booster (a 5th vaccine dose). Here's why.
I've got leukaemia and caught Covid two weeks ago
Stephen Pollard, Editor at large for the Jewish Chronicle, lives with chronic lymphocytic leukaemia and has spent the last couple of years trying to avoid Covid. But two weeks ago, he tested positive. We asked him to write about his experience.
How our blood cancer and Covid survey has led to change
We’re writing this to update you on what our recent survey on blood cancer and Covid found, what has happened since, and the impact it made.
“Alarming” racial inequality in third vaccine doses for the immunocompromised
New data has shown that take-up of the third vaccine dose among white British people is almost double that of some ethnic minorities. Here's our response.
Latest Updates from the Vaccine Research Collaborative
Welcome to our live blog all about research looking at the effectiveness of the covid vaccines in people with blood cancer.
Blood Cancer UK’s approach to in-person events
Our Chief Executive, Gemma Peters, explains our decision to hold in-person events again.
Omicron variant and people with blood cancer
What can people with blood cancer and those around them do about the risk of Omicron?
Why am I being invited for another Covid vaccine? - Third doses and boosters
Anyone who is immunocompromised, including anyone with blood cancer, is now eligible for a booster (fourth dose) of the Covid vaccine, to be given three months after their third primary dose. In this blog, we explain more.
Antivirals and monoclonal antibodies – what’s the difference?
We’ve been hearing about new treatments that the UK have bought to tackle Covid. Some drugs have already been approved for use in the UK, some are yet to be – but the hope is that they will help those most at risk of severe Covid.
What should you do if you have blood cancer and cannot get a third Covid vaccine dose?
With many people reporting issues with the rollout of third doses of the vaccine, we’ve set out what you can do right now to try to get your third dose if you have not already been invited for it.
Booster vaccines: How we helped make the research happen
Beating blood cancer isn't just about spending money on research, but bringing the right people together at the right time. In this blog, we explain how we helped make booster vaccine research happen and how we see ourselves as a convener of research as well as a funder.
Five reasons for people with blood cancer to be hopeful about the Covid pandemic
We know that many of you are worried about Covid, which is we why we want you to know that with more research into vaccine efficacy, and with better treatments on the horizon, there are reasons for you to be optimistic about the future.
What do covid antibody test results mean for people with blood cancer?
Many of our community have had an antibody test following their covid vaccine to understand what kind of response they’ve had. In this blog, we talk more about what antibody test results mean, what the evidence suggests is important in developing a response to vaccination and what other factors are important to think about.
Group of charities announce first blood cancer vaccine efficacy research funding
A new collaborative of charities focusing on research into COVID-19 vaccine efficacy for people with blood cancer has announced funding for research into how well they work in people with cancer that affects their immune system.
What else can we use to protect people with blood cancer from covid?
We spoke to Professor Andrew Ustianowski, the clinical lead of a trial called PROVENT, to find out about alternative methods that might protect people with blood cancer from covid.
How dangerous is Covid-19 for people with blood cancer?
New research has been published that sheds new light on how dangerous the coronavirus is to people with blood cancer.
Professors Van-Tam and Vallance's comments show vaccine priority must change
Following comments by Jonathan Van-Tam and Patrick Vallance that vaccines are almost certain to prevent covid transmission, we're urging the Government to give adults living with people with blood cancer a higher vaccine priority
